Company profile KALA
There is not enough data for KALA BIO KALA BIO stock to provide analysis
There is not enough data for KALA BIO KALA BIO stock to provide correlation calculation
There is not enough data for KALA BIO KALA BIO stock to provide analysis
After 39 days of this quarter the interest is at 13.0. Based on that we can calculate that during remaining 52 days it will total up to 30.0. KALA Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-63.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 60 | 91 51.7% QoQ | 97 6.6% QoQ | 69 -28.9% QoQ |
| 2020 | 129 115.0% YoY 87.0% QoQ | 80 -12.1% YoY -38.0% QoQ | 124 27.8% YoY 55.0% QoQ | 173 150.7% YoY 39.5% QoQ |
| 2021 | 128 -0.8% YoY -26.0% QoQ | 127 58.8% YoY -0.8% QoQ | 88 -29.0% YoY -30.7% QoQ | 84 -51.4% YoY -4.5% QoQ |
| 2022 | 100 -21.9% YoY 19.0% QoQ | 93 -26.8% YoY -7.0% QoQ | 53 -39.8% YoY -43.0% QoQ | 137 63.1% YoY 158.5% QoQ |
| 2023 | 81 -19.0% YoY -40.9% QoQ | 79 -15.1% YoY -2.5% QoQ | 13 -75.5% YoY -83.5% QoQ | 44 -67.9% YoY 238.5% QoQ |
| 2024 | 13 -84.0% YoY -70.5% QoQ | - | - | - |
The average 5 years interest of KALA Pharmaceuticals was 7.14 per week. The last year interest of KALA Pharmaceuticals compared to the last 5 years has changed by -49.86%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -48.41%.
There is not enough data for KALA BIO news to provide analysis
There is not enough data for KALA BIO news to provide correlation calculation
There is not enough data for KALA BIO news to provide analysis
After 34 days of this quarter the interest is at 298.0. Based on that we can calculate that during remaining 58 days it will total up to 806.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 202 |
| 2019 | 346 71.3% QoQ | 427 23.4% QoQ | 374 -12.4% QoQ | 417 106.4% YoY 11.5% QoQ |
| 2020 | 527 52.3% YoY 26.4% QoQ | 530 24.1% YoY 0.6% QoQ | 597 59.6% YoY 12.6% QoQ | 616 47.7% YoY 3.2% QoQ |
| 2021 | 604 14.6% YoY -1.9% QoQ | 582 9.8% YoY -3.6% QoQ | 566 -5.2% YoY -2.7% QoQ | 553 -10.2% YoY -2.3% QoQ |
| 2022 | 731 21.0% YoY 32.2% QoQ | 786 35.1% YoY 7.5% QoQ | 676 19.4% YoY -14.0% QoQ | 631 14.1% YoY -6.7% QoQ |
| 2023 | 873 19.4% YoY 38.4% QoQ | 916 16.5% YoY 4.9% QoQ | 728 7.7% YoY -20.5% QoQ | 298 -52.8% YoY -59.1% QoQ |
The average 5 years interest of eye disease treatment was 46.08 per week. The last year interest of eye disease treatment compared to the last 5 years has changed by 34.09%. The interest for eye disease treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 112.78%.
There is not enough data for KPI-012 clinical trial to provide analysis
There is not enough data for KPI-012 clinical trial to provide correlation calculation
There is not enough data for KPI-012 clinical trial to provide analysis
There is not enough data for EYSUVIS dry eye treatment to provide analysis
There is not enough data for EYSUVIS dry eye treatment to provide correlation calculation
There is not enough data for EYSUVIS dry eye treatment to provide analysis
There is not enough data for INVELTYS ocular surgery treatment to provide analysis
There is not enough data for INVELTYS ocular surgery treatment to provide correlation calculation
There is not enough data for INVELTYS ocular surgery treatment to provide analysis
Google Trends for KPI-014 rare inherited retinal diseases
Not enough data for reliable calculations!
There is not enough data for KPI-014 rare inherited retinal diseases to provide analysis
There is not enough data for KPI-014 rare inherited retinal diseases to provide correlation calculation
There is not enough data for KPI-014 rare inherited retinal diseases to provide analysis